Tag: Pharma
India gets its first indigenous antibiotic ‘Nafithromycin’ to combat drug resistance
New antibiotic offers 10x efficacy with just 3 doses to combat drug-resistant pneumonia
Delhi -NCR all set to host CPHI & PMEC India on...
The Expo will bring together over 50000 visitors and 2000 exhibitors providing a unique environment for industry experts to share ideas and drive their business forward
Pfizer INDovation program boosts six healthcare startups with INR 1.5 Crore...
The Pfizer INDovation NIPER-A edition is supported by Pfizer Limited, and the Department of Pharmaceuticals, NITI Aayog, NIPER-Ahmedabad and Social Alpha as anchor partners to back indigenous healthcare solutions to advance India’s healthcare priorities
Emcure Pharma records Rs 2,002 crore operational revenue with 20% revenue...
EBITDA margins at 20.8% with EBITDA up 26.1% YoY and 15.8% QoQ
Top 20 global biopharma players witness 2% growth in market capitalization...
Industry leaders are driving innovation by advancing their R&D pipelines and entering billion-dollar strategic alliances
Novel molecules developed to treat Alzheimer’s disease
These non-toxic molecules could be effective in the treatment of the disease
Emcure Pharma launches Emcutix Biopharma to expand dermatology offerings
The focus will be on building a differentiated product portfolio including first-time launches designed to fulfil the unmet needs of the Indian dermatology market
IPA organizes 9th Advanced GMP Workshop 2024
The two-day workshop held virtually featured over 25 distinguished industry leaders, subject matter experts, and global regulators, including USFDA and CDSCO
FDA approves Accord BioPharma’s biosimilar ‘IMULDOSA’ to treat chronic inflammatory conditions
Accord BioPharma (A division of Intas Pharmaceuticals) anticipates a commercial launch of IMULDOSA in the first half of 2025
Epigenetic drugs witness 375% growth in series A venture financing in...
GlobalData’s Pharma Intelligence Center Deals Database reveals that companies developing epigenetic drugs received over $1 billion in total series A venture financing from 2019 to 2024YTD